- Preparation of oxodihydropyridine derivatives and analogs for use as bromodomain inhibitors, World Intellectual Property Organization, , ,
Cas no 942947-94-6 (5-Bromo-4-chloropyridin-2-amine)
942947-94-6 structure
Product Name:5-Bromo-4-chloropyridin-2-amine
CAS No:942947-94-6
MF:C5H4BrClN2
MW:207.455658912659
MDL:MFCD12407282
CID:93238
PubChem ID:44181812
Update Time:2024-10-25
5-Bromo-4-chloropyridin-2-amine Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromo-4-chloropyridin-2-amine
- 2-Pyridinamine, 5-bromo-4-chloro-
- 5-Bromo-4-chloro-2-aminopyridine
- 5-BROMO-4-CHLORO-2-PYRIDINAMINE
- 5-Bromo-4-chloro-pyridin-2-ylamine
- 2-Amino-4-chloro-5-bromopyridine
- 2-Amino-5-bromo-4-chloroPyridine
- 5-bromo-4-chloro-2-pyridylamine
- 5-Bromo-4-chloro-2-amino pyridine
- PubChem13538
- DDOFUMWLNSICHU-UHFFFAOYSA-N
- 4-Chloro-5-bromopyridine-2-amine
- PB17989
- VP12952
- 5-Bromo-4-chlor
- 5-Bromo-4-chloro-2-pyridinamine (ACI)
- (5-Bromo-4-chloropyridin-2-yl)amine
- MFCD12407282
- 5-Bromo-4-chloropyridin-2-amine, 98%
- AC-907/34104026
- J-517073
- CS-W009193
- AKOS015889463
- 942947-94-6
- AS-18620
- SY030928
- AC-27481
- AM20061634
- SCHEMBL211570
- EN300-192313
- BL010015
- BDBM626074
- FT-0653509
- DTXSID60657711
- S5NXK6YT42
- DB-079845
-
- MDL: MFCD12407282
- Inchi: 1S/C5H4BrClN2/c6-3-2-9-5(8)1-4(3)7/h1-2H,(H2,8,9)
- InChI Key: DDOFUMWLNSICHU-UHFFFAOYSA-N
- SMILES: BrC1=CN=C(C=C1Cl)N
Computed Properties
- Exact Mass: 205.92500
- Monoisotopic Mass: 205.925
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 9
- Rotatable Bond Count: 0
- Complexity: 101
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 38.9
- XLogP3: 1.8
Experimental Properties
- Density: 1.8
- Melting Point: 141-147°C
- Boiling Point: 271.5°C at 760 mmHg
- Flash Point: 118.038 °C
- Refractive Index: 1.64
- PSA: 38.91000
- LogP: 2.66090
5-Bromo-4-chloropyridin-2-amine Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Storage Condition:Keep in dark place,Inert atmosphere,2-8°C
- HazardClass:6.1
- PackingGroup:III
5-Bromo-4-chloropyridin-2-amine Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Bromo-4-chloropyridin-2-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A029016484-250mg |
2-Amino-5-bromo-4-chloropyridine |
942947-94-6 | 95% | 250mg |
$931.00 | 2023-08-31 | |
| Alichem | A029016484-1g |
2-Amino-5-bromo-4-chloropyridine |
942947-94-6 | 95% | 1g |
$2866.05 | 2023-08-31 | |
| Fluorochem | 079650-1g |
5-Bromo-4-chloropyridin-2-amine |
942947-94-6 | 97% | 1g |
£10.00 | 2022-03-01 | |
| Fluorochem | 079650-5g |
5-Bromo-4-chloropyridin-2-amine |
942947-94-6 | 97% | 5g |
£41.00 | 2022-03-01 | |
| Fluorochem | 079650-10g |
5-Bromo-4-chloropyridin-2-amine |
942947-94-6 | 97% | 10g |
£73.00 | 2022-03-01 | |
| Fluorochem | 079650-25g |
5-Bromo-4-chloropyridin-2-amine |
942947-94-6 | 97% | 25g |
£180.00 | 2022-03-01 | |
| ChemScence | CS-W009193-5g |
2-Amino-5-bromo-4-chloropyridine |
942947-94-6 | 99.12% | 5g |
$39.0 | 2021-09-02 | |
| ChemScence | CS-W009193-10g |
2-Amino-5-bromo-4-chloropyridine |
942947-94-6 | 99.12% | 10g |
$76.0 | 2022-04-26 | |
| ChemScence | CS-W009193-25g |
2-Amino-5-bromo-4-chloropyridine |
942947-94-6 | 99.12% | 25g |
$113.0 | 2022-04-26 | |
| ChemScence | CS-W009193-100g |
2-Amino-5-bromo-4-chloropyridine |
942947-94-6 | 99.12% | 100g |
$396.0 | 2022-04-26 |
5-Bromo-4-chloropyridin-2-amine Production Method
Production Method 1
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; rt; 16 h, rt
Reference
Production Method 2
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; rt; 14 h, rt
Reference
- Preparation of aryl lactam kinase inhibitors useful in inhibiting AAK1, United States, , ,
Production Method 3
Reaction Conditions
1.1 Reagents: Acetic acid Solvents: Tetrahydrofuran ; rt → 0 °C
1.2 Reagents: N-Bromosuccinimide Solvents: Tetrahydrofuran ; 1.5 h, 0 - 10 °C; 2 h, 0 - 10 °C
1.3 Reagents: Sodium hydroxide Solvents: Toluene , Water
1.2 Reagents: N-Bromosuccinimide Solvents: Tetrahydrofuran ; 1.5 h, 0 - 10 °C; 2 h, 0 - 10 °C
1.3 Reagents: Sodium hydroxide Solvents: Toluene , Water
Reference
- Processe to make protein kinase inhibitor N-[4-[4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl]phenyl]-N'-(3-fluorophenyl)urea, World Intellectual Property Organization, , ,
Production Method 4
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Dichloromethane ; 0 °C; 30 min
Reference
- A process for preparing 5-bromo-2,4-dichloro-pyridine from 4-chloro-2-pyridinamine, China, , ,
Production Method 5
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; 6 h, rt
Reference
- Synthesis of Hpk1 degrader anticancer agents, World Intellectual Property Organization, , ,
Production Method 6
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; 3 h, rt
Reference
- Preparation of 2-aminopyridine compounds useful in treating hyperproliferative diseases, World Intellectual Property Organization, , ,
Production Method 7
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; rt; 16 h, rt
Reference
- Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development CandidateBavetsias, Vassilios; Large, Jonathan M.; Sun, Chongbo; Bouloc, Nathalie; Kosmopoulou, Magda; et al, Journal of Medicinal Chemistry, 2010, 53(14), 5213-5228
Production Method 8
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; rt; 16 h, rt
Reference
- Preparation of imidazopyridines as enzyme inhibitors, especially Aurora kinase inhibitors, for treating cell proliferative diseases, World Intellectual Property Organization, , ,
Production Method 9
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; 12 h, rt
Reference
- Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient, Korea, , ,
Production Method 10
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; rt; 14 h, rt
Reference
- Preparation of chromenopyridine derivatives for use as adaptor associated kinase 1 inhibitors, World Intellectual Property Organization, , ,
Production Method 11
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; 14 h, rt
Reference
- Preparation of chromenopyridinyloxyalkylamine derivatives for use as adaptor associated kinase 1 inhibitors, World Intellectual Property Organization, , ,
Production Method 12
Reaction Conditions
1.1 Reagents: Tetrabutylammonium bromide , Lithium perchlorate Solvents: Acetic acid , Acetonitrile ; 16 h, 25 °C
Reference
- Electrochemical synthesis method of bromopyridine derivatives, China, , ,
Production Method 13
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile ; 3 h, rt
Reference
- Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Stieber, Frank; Calderini, Michel; et al, Journal of Medicinal Chemistry, 2016, 59(3), 1078-1101
Production Method 14
Reaction Conditions
1.1 Reagents: Bromine Solvents: Acetonitrile ; 30 min, 0 °C; 0 °C → rt; overnight, rt
Reference
- Tricyclic pyridocarboxamide derivatives as ROCK inhibitors and their preparation, World Intellectual Property Organization, , ,
Production Method 15
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile
Reference
- Imidazo[1,2-a]pyridine compounds as tyrosine kinase c-Met signal transduction pathway inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cell hyperplasia diseases, World Intellectual Property Organization, , ,
Production Method 16
Reaction Conditions
1.1 Reagents: N-Bromosuccinimide Solvents: Acetonitrile
Reference
- Preparation of chromenopyridine derivatives for use as AAK1 inhibitors, World Intellectual Property Organization, , ,
Production Method 17
Reaction Conditions
1.1 Reagents: Tetrabutylammonium bromide , Lithium perchlorate Solvents: Acetic acid , Acetonitrile ; 8 h, 25 °C
Reference
- Directing Group Enables Electrochemical Selectively Meta-Bromination of Pyridines under Mild ConditionsWu, Yanwei; Xu, Shanghui; Wang, Hong; Shao, Dongxu; Qi, Qiqi; et al, Journal of Organic Chemistry, 2021, 86(22), 16144-16150
5-Bromo-4-chloropyridin-2-amine Raw materials
5-Bromo-4-chloropyridin-2-amine Preparation Products
5-Bromo-4-chloropyridin-2-amine Related Literature
-
Jadwiga Frelek,Marcin Górecki,Marta ?aszcz,Agata Suszczyńska,Elemér Vass,Wojciech J. Szczepek Chem. Commun., 2012,48, 5295-5297
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
942947-94-6 (5-Bromo-4-chloropyridin-2-amine) Related Products
- 1131604-99-3(5-Bromo-4-chloropyridine-2,3-diamine)
- 1823969-53-4(5-Bromo-4-chloro-N,N-dimethylpyridin-2-amine)
- 1242329-23-2(3,5-dibromo-4-chloropyridin-2-amine)
- 917969-29-0(Pyridine, 3-bromo-4-chloro-2-hydrazinyl-)
- 1607837-98-8(5-Bromo-3,4-dichloropyridin-2-amine)
- 221297-82-1(3-Bromo-4-chloropyridin-2-amine)
- 2256740-10-8(5-bromo-4-chloropyridin-3,6-d2-2-amine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
Recommended suppliers
Nanjing jingzhu bio-technology Co., Ltd.
Gold Member
CN Supplier
Bulk
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
CN Supplier
Reagent
Beyond Pharmaceutical Co., Ltd
Gold Member
CN Supplier
Reagent
Hebei Liye chemical Co.,Ltd
Gold Member
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Gold Member
CN Supplier
Bulk